Executive Vice President & President,
Specialty Care International & Global Franchises
Harout Semerjian was appointed Executive Vice-President & President , Specialty Care International & Global Franchises, in February 2017. Harout has more than 23 years of pharmaceutical experience, including the last 17 years at Novartis focused on oncology and specialty care. He took on leadership roles with increasing responsibility across the U.S., Canada, Europe, Middle East & North Africa in addition to headquarter-based roles. His last role was Senior Vice President and Global Launch Head of ribociclib. Prior to that, he was Vice President and U.S. Hematology Franchise Head based in New Jersey. He holds dual MBA degrees from Cornell University, New York and from Queen’s University, Canada. He also holds a Bachelor Degree of Science in Biology from the Lebanese American University. Chris has been a member of the Parenteral Drug Society for the last 20 years. He is a respected leader and strategist in global Pharmaceutical Quality, and has led numerous successful health authority inspections with agencies including FDA, European agencies such as MPA (Sweden), MHRA (UK) and AIFA (Italy) as well as Irish, Brazilian, Japanese, Chinese and Middle East authorities. Chris is a microbiologist with a degree from the University of Massachusetts at Amherst in the USA.
Quality culture and embedded Quality in pharmaceutical